Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease
Emily K Wright, Michael A Kamm, Peter De Cruz, Amy L Hamilton, Fabiyola Selvaraj, Fred Princen, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian C Lawrance, Jane M Andrews, Peter A Bampton, Simon L Jakobovits, Timothy H Florin, Peter R Gibson, Henry Debinski, Finlay A Macrae, Douglas Samuel, Ian Kronborg, Graham Radford-Smith Show all
Journal of Crohn's and Colitis | OXFORD UNIV PRESS | Published : 2018
Prometheus Laboratories [San Diego, CA, USA] undertook all drug concentration analyses. AbbVie, Gutsy Group, Gandel Philanthropy, Angior Foundation and Crohn's Colitis Australia provided funding for the conduct of the POCER study. The National Health and Medical Research Council [NHMRC] supported EKW, PDC and MAK. St Vincent's Research Foundation supported MAK.